Loading stock data…
Loading stock data…
US$8.29
Get one email when CRMD crosses your level. Checked every 15 minutes during market hours.
▼ -0.13 (-1.54%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
47.7
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.03
Bearish momentumMACD below its signal line (0.06).
50-day average
8.28
Price aboveShort-term trend reference.
200-day average
8.83
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening conditions, particularly in anti-infective therapies and hospital-based treatments in the United States. Its lead product, DefenCath, is an FDA-approved antimicrobial catheter lock solution containing taurolidine and heparin, designed to reduce catheter-related bloodstream infections in adult patients with kidney failure undergoing chronic hemodialysis via central veno…
www.cormedix.com3 strong buy · 7 buy · 1 hold · 0 sell · 0 strong sell (11 analysts, 2026-07-01)
3 strong buy · 8 buy · 1 hold · 0 sell · 0 strong sell (12 analysts, 2026-06-01)
3 strong buy · 9 buy · 1 hold · 0 sell · 0 strong sell (13 analysts, 2026-05-01)
3 strong buy · 9 buy · 1 hold · 0 sell · 0 strong sell (13 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-14 | 0.33 | 0.35 | ✓ Beat |
| 2026-04-15 | 0.5 | 0.53 | ✓ Beat |
| 2026-03-05 | 0.81 | 0.16 | ✗ Miss |
| 2025-11-12 | 0.63 | 1.41 | ✓ Beat |
| 2025-08-07 | 0.19 | 0.28 | ✓ Beat |
| 2025-05-06 | 0.25 | 0.3 | ✓ Beat |
| 2025-03-25 | 0.14 | 0.22 | ✓ Beat |
Companies in the same industry, via Finnhub